PharOs, which began its operations in Greece in 2002, is engaged in the development, approval, production and distribution of generic pharmaceutical products. PharOs currently owns a range of 68 products, 34 of which have been launched and 7,000 under marketing authorizations. The Company’s products are sold in 90 countries. In 2018, the Company established a production plant in Malta.
Sector: Generic Pharmaceuticals
No. of Employees: 297
Management Team: Stella Koukaki, Theodore Panagopoulos, Panagiotis Panagopoulos
Investment Date: August 2019
Company website: https://www.pharosgr.gr